500mg saquinavir (Invirase) approved in Europe
15 June 2005. Related: Antiretrovirals.
2005
Roche to withdraw saquinavir soft gel caps (Fortovase)
15 June 2005. Related: Antiretrovirals.
FDA approve lopinavir/r once daily for treatment naive patients
15 June 2005. Related: Antiretrovirals.
Safety data for tenofovir updated
15 June 2005. Related: Antiretrovirals.
FDA approve entecavir for HBV
15 June 2005. Related: Antiretrovirals.
Efavirenz warning in pregnancy strengthened
15 June 2005. Related: Antiretrovirals.
New ritonavir interactions
15 June 2005. Related: Antiretrovirals.
FDA advisory committee recommends approval for tipranavir – material from hearing online
15 June 2005. Related: Antiretrovirals.
US adult treatment guidelines updated (2005)
15 June 2005. Related: Guidelines.
Application for meltrex formulation of Kaletra submitted to the FDA
15 June 2005. Related: Antiretrovirals.
TAC electronic newsletter
15 June 2005. Related: On the web.
Articles from AIDS Treatment News
15 June 2005. Related: On the web.
AIDS Vaccine Advocacy Coalition (AVAC) publishes new AIDS Vaccine Handbook
15 June 2005. Related: On the web.
WHO lists reliable web sites on vaccines
15 June 2005. Related: On the web.
Volume 6 Number 6 June 2005 PDF
1 June 2005. Related: PDFs.
Volume 6 Number 5 May 2005
15 May 2005. Related: Editorial.
3rd European HIV Drug Resistance Workshop, 30 March-1 April 2005, Athens
15 May 2005. Related: Conference reports.
Tenofovir, nucleosides, and non-nucleosides
15 May 2005. Related: Conference reports, Drug resistance.
Protease inhibitors
15 May 2005. Related: Conference reports, Drug resistance.
CCR5 antagonists
15 May 2005. Related: Conference reports, Drug resistance.
Paediatric reports from 12th Conference on Retrovirus and Opportunistic Infections (CROI)
15 May 2005. Related: Conference reports.
Once-daily lopinavir/ritonavir for children may offer advantages
15 May 2005. Related: Conference reports, Paediatric care.
Lopinavir/ritonavir for young infants
15 May 2005. Related: Conference reports, Paediatric care.
Paediatric dose finding atazanavir and atazanavir/ritonavir
15 May 2005. Related: Conference reports, Paediatric care.
Switching d4T to tenofovir and protease inhibitor to efavirenz
15 May 2005. Related: Conference reports, Paediatric care.
40th European Association for the Study of the Liver (EASL)
15 May 2005. Related: On the web.
Millions in Global Fund grants go unused: Indian government bureaucracies kill off people living with AIDS
15 May 2005. Related: Treatment access.
Draft BHIVA treatment guidelines online for comment
15 May 2005. Related: Guidelines.
US guidelines on paediatric care updated (March 2005)
15 May 2005. Related: Paediatric care, Guidelines.
UK guidelines for liver transplant in HIV-positive patients
15 May 2005. Related: Guidelines, Hepatitis coinfection.
Sexual HCV reinfection of HIV-positive gay man while receiving PEG-interferon plus ribavirin
15 May 2005. Related: Hepatitis coinfection.
First European recommendations for the treatment of patients co-infected with HIV and HBV/HCV
15 May 2005. Related: Hepatitis coinfection.
Newly acquired HIV infections are key to transmission
15 May 2005. Related: Other news.
Calls to i-Base phoneline now free from Orange mobile networks
15 May 2005. Related: Other news.
Request for overseas volunteers
15 May 2005. Related: Other news.
Community impact of New York case of HIV infection with multidrug-resistant dual-tropic HIV-1 and rapid progression to AIDS
15 May 2005. Related: On the web.
Integration of buprenorphine into primary HIV care
15 May 2005. Related: On the web.
HIV inSite Knowledge Base
15 May 2005. Related: On the web.
Lymphogranuloma venereum – an overview: update on UK cases of LGV
10 May 2005. Related: Coinfections and complications.
Volume 6 Number 5 May 2005 PDF
1 May 2005. Related: PDFs.
Volume 6 Number 4 April 2005
19 April 2005. Related: Editorial.
Drug-induced hepatitis in healthy volunteers receiving rifampicin 600mg daily in combination with ritonavir 100mg and saquinavir 1000mg twice daily (boosted saquinavir)
18 April 2005. Related: Treatment alerts.
New European recommendations regarding the co-administration of ddI (Videx) and tenofovir DF (Viread)
18 April 2005. Related: Treatment alerts.
12th Conference on Retrovirus and Opportunistic Infections, 22-25 February, Boston, 2005
18 April 2005. Related: Conference reports.
Developments in nevirapine use in MTCT reduction
18 April 2005. Related: Conference reports, Pregnancy.
Mashi study – late breakers on breastfeeding
18 April 2005. Related: Conference reports, Pregnancy.
Maternal health and infant mortality
18 April 2005. Related: Conference reports, Pregnancy.
Paediatric care in lower income settings
18 April 2005. Related: Conference reports, Paediatric care.
Tenofovir not linked to bone toxicity in children followed for one year
18 April 2005. Related: Conference reports, Paediatric care.
Gut memory CD4 T cells implicated in a central role for HIV disease pathology: dramatic impact prior to seroconversion
18 April 2005. Related: Conference reports, Basic science and immunology.
Case of multi-drug resistant (MDR) rapid progressor
18 April 2005. Related: Conference reports, Basic science and immunology.
Case report of antibody reversion and negative viral load four-years after treatment discontinuation
18 April 2005. Related: Conference reports, Basic science and immunology.
24-week efficacy of TMC114 in PI-experienced patients
18 April 2005. Related: Conference reports, Antiretrovirals.
Maturation inhibitor shows anti-HIV activity in single dose pilot study
18 April 2005. Related: Conference reports, Antiretrovirals.
New antiretrovirals at 12th CROI
18 April 2005. Related: Conference reports, Antiretrovirals.
Absolute risk is modest, but cumulative cardiovascular risk of HAART over five years is similar to ‘ever smoked’: new data on gender and age
18 April 2005. Related: Conference reports, Side effects.
Omega-3 supplement effective to reduce triglycerides
18 April 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Entecavir is effective against 3TC-resistant hepatitis B
18 April 2005. Related: Conference reports, Hepatitis coinfection.
Switch to tenofovir from AZT or d4T improves fat loss and improves lipid parameters compared to abacavir
18 April 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Continued use of a thymidine analogue may limit benefit from rosiglitazone when used to treat lipoatrophy
18 April 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Tenofovir is non-inferior to adefovir for the treatment of hepatitis B in HBV-HIV co-infected patients
18 April 2005. Related: Conference reports, Hepatitis coinfection.
Demand for two originator ARVs could soon exceed supply
18 April 2005. Related: Treatment access.
Indian patent bill is introduced with no change: the beginning of the end of generics?
18 April 2005. Related: Treatment access.
Patent mailbox opened in India
18 April 2005. Related: Treatment access.
GSK calls on UK to use G8 presidency to enforce patents
18 April 2005. Related: Treatment access.